Pharmaceuticals 2009, 2(3), 94-117; doi:10.3390/ph2030094
Review

Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene

Huntsman Cancer Institute and Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA
Received: 27 October 2009; in revised form: 10 November 2009 / Accepted: 19 November 2009 / Published: 20 November 2009
(This article belongs to the Special Issue Biomarkers)
PDF Full-text Download PDF Full-Text [349 KB, uploaded 20 November 2009 10:17 CET]
Abstract: In the past several years a number of alterations in the PAFAH/PLA2G7/LpPLA2 gene have been described. These include inactivating mutations, polymorphisms in the coding region, and other genetic changes located in promoter and intronic regions of the gene. The consequences associated with these genetic variations have been evaluated from different perspectives, including in vitro biochemical and molecular studies and clinical analyses in human subjects. This review highlights the current state of the field and suggests new approaches that can be used to evaluate functional consequences associated with mutations and polymorphisms in the PAF-AH gene.
Keywords: PAF acetylhydrolase; PLA2G7; single nucleotide polymorphism; mutation; vascular disease

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Stafforini, D.M. Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene. Pharmaceuticals 2009, 2, 94-117.

AMA Style

Stafforini DM. Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene. Pharmaceuticals. 2009; 2(3):94-117.

Chicago/Turabian Style

Stafforini, Diana M. 2009. "Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene." Pharmaceuticals 2, no. 3: 94-117.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert